Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α

Jennifer E. Foreman, Shu Ching Chang, David J. Ehresman, John L. Butenhoff, Cherie R. Anderson, Prajakta S. Palkar, Boo Hyon Kang, Frank J. Gonzalez, Jeffrey Maurice Peters

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Perfluorobutryate (PFBA) is a short chain perfluoroalkyl carboxylate that is structurally similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, induction of peroxisomal fatty acid oxidation and hepatomegaly, suggesting that PFBA activates the nuclear receptor, peroxisome proliferator-activated receptor-α (PPAR-α). In this study, the role of PPAR-α in mediating the effects of PFBA was examined using PPAR-α null mice and a mouse line expressing the human PPAR-α in the absence of mouse PPAR-α (PPAR-α humanized mice). PFBA caused upregulation of known PPAR-α target genes that modulate lipid metabolism in wild-type and PPAR-α humanized mice, and this effect was not found in PPAR-α null mice. Increased liver weight and hepatocyte hypertrophy were also found in wild-type and humanized PPAR-α mice treated with PFBA, but not in PPAR-α null mice. Interestingly, hepatocyte focal necrosis with inflammatory cell infiltrate was only found in wild-type mice administered PFBA; this effect was markedly diminished in both PPAR-α null and PPAR-α humanized mice. Results from these studies demonstrate that PFBA can modulate gene expression and cause mild hepatomegaly and hepatocyte hypertrophy through a mechanism that requires PPAR-α and that these effects do not exhibit a species difference. In contrast, the PPAR-α-dependent increase in PFBA-induced hepatocyte focal necrosis with inflammatory cell infiltrate was mediated by the mouse PPAR-α but not the human PPAR-α. Collectively, these findings demonstrate that PFBA can activate both the mouse and human PPAR-α, but there is a species difference in the hepatotoxic response to this chemical.

Original languageEnglish (US)
Pages (from-to)204-211
Number of pages8
JournalToxicological Sciences
Volume110
Issue number1
DOIs
StatePublished - Jun 29 2009

Fingerprint

Peroxisome Proliferator-Activated Receptors
Liver
Hepatocytes
perfluorobutyric acid
perfluorooctanoic acid
Hepatomegaly
Hypertrophy
Necrosis
Peroxisomes

All Science Journal Classification (ASJC) codes

  • Toxicology

Cite this

Foreman, J. E., Chang, S. C., Ehresman, D. J., Butenhoff, J. L., Anderson, C. R., Palkar, P. S., ... Peters, J. M. (2009). Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α. Toxicological Sciences, 110(1), 204-211. https://doi.org/10.1093/toxsci/kfp077
Foreman, Jennifer E. ; Chang, Shu Ching ; Ehresman, David J. ; Butenhoff, John L. ; Anderson, Cherie R. ; Palkar, Prajakta S. ; Kang, Boo Hyon ; Gonzalez, Frank J. ; Peters, Jeffrey Maurice. / Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α. In: Toxicological Sciences. 2009 ; Vol. 110, No. 1. pp. 204-211.
@article{ce0ee9d203ef48b284a6b438f7a2d449,
title = "Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α",
abstract = "Perfluorobutryate (PFBA) is a short chain perfluoroalkyl carboxylate that is structurally similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, induction of peroxisomal fatty acid oxidation and hepatomegaly, suggesting that PFBA activates the nuclear receptor, peroxisome proliferator-activated receptor-α (PPAR-α). In this study, the role of PPAR-α in mediating the effects of PFBA was examined using PPAR-α null mice and a mouse line expressing the human PPAR-α in the absence of mouse PPAR-α (PPAR-α humanized mice). PFBA caused upregulation of known PPAR-α target genes that modulate lipid metabolism in wild-type and PPAR-α humanized mice, and this effect was not found in PPAR-α null mice. Increased liver weight and hepatocyte hypertrophy were also found in wild-type and humanized PPAR-α mice treated with PFBA, but not in PPAR-α null mice. Interestingly, hepatocyte focal necrosis with inflammatory cell infiltrate was only found in wild-type mice administered PFBA; this effect was markedly diminished in both PPAR-α null and PPAR-α humanized mice. Results from these studies demonstrate that PFBA can modulate gene expression and cause mild hepatomegaly and hepatocyte hypertrophy through a mechanism that requires PPAR-α and that these effects do not exhibit a species difference. In contrast, the PPAR-α-dependent increase in PFBA-induced hepatocyte focal necrosis with inflammatory cell infiltrate was mediated by the mouse PPAR-α but not the human PPAR-α. Collectively, these findings demonstrate that PFBA can activate both the mouse and human PPAR-α, but there is a species difference in the hepatotoxic response to this chemical.",
author = "Foreman, {Jennifer E.} and Chang, {Shu Ching} and Ehresman, {David J.} and Butenhoff, {John L.} and Anderson, {Cherie R.} and Palkar, {Prajakta S.} and Kang, {Boo Hyon} and Gonzalez, {Frank J.} and Peters, {Jeffrey Maurice}",
year = "2009",
month = "6",
day = "29",
doi = "10.1093/toxsci/kfp077",
language = "English (US)",
volume = "110",
pages = "204--211",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

Foreman, JE, Chang, SC, Ehresman, DJ, Butenhoff, JL, Anderson, CR, Palkar, PS, Kang, BH, Gonzalez, FJ & Peters, JM 2009, 'Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α', Toxicological Sciences, vol. 110, no. 1, pp. 204-211. https://doi.org/10.1093/toxsci/kfp077

Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α. / Foreman, Jennifer E.; Chang, Shu Ching; Ehresman, David J.; Butenhoff, John L.; Anderson, Cherie R.; Palkar, Prajakta S.; Kang, Boo Hyon; Gonzalez, Frank J.; Peters, Jeffrey Maurice.

In: Toxicological Sciences, Vol. 110, No. 1, 29.06.2009, p. 204-211.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α

AU - Foreman, Jennifer E.

AU - Chang, Shu Ching

AU - Ehresman, David J.

AU - Butenhoff, John L.

AU - Anderson, Cherie R.

AU - Palkar, Prajakta S.

AU - Kang, Boo Hyon

AU - Gonzalez, Frank J.

AU - Peters, Jeffrey Maurice

PY - 2009/6/29

Y1 - 2009/6/29

N2 - Perfluorobutryate (PFBA) is a short chain perfluoroalkyl carboxylate that is structurally similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, induction of peroxisomal fatty acid oxidation and hepatomegaly, suggesting that PFBA activates the nuclear receptor, peroxisome proliferator-activated receptor-α (PPAR-α). In this study, the role of PPAR-α in mediating the effects of PFBA was examined using PPAR-α null mice and a mouse line expressing the human PPAR-α in the absence of mouse PPAR-α (PPAR-α humanized mice). PFBA caused upregulation of known PPAR-α target genes that modulate lipid metabolism in wild-type and PPAR-α humanized mice, and this effect was not found in PPAR-α null mice. Increased liver weight and hepatocyte hypertrophy were also found in wild-type and humanized PPAR-α mice treated with PFBA, but not in PPAR-α null mice. Interestingly, hepatocyte focal necrosis with inflammatory cell infiltrate was only found in wild-type mice administered PFBA; this effect was markedly diminished in both PPAR-α null and PPAR-α humanized mice. Results from these studies demonstrate that PFBA can modulate gene expression and cause mild hepatomegaly and hepatocyte hypertrophy through a mechanism that requires PPAR-α and that these effects do not exhibit a species difference. In contrast, the PPAR-α-dependent increase in PFBA-induced hepatocyte focal necrosis with inflammatory cell infiltrate was mediated by the mouse PPAR-α but not the human PPAR-α. Collectively, these findings demonstrate that PFBA can activate both the mouse and human PPAR-α, but there is a species difference in the hepatotoxic response to this chemical.

AB - Perfluorobutryate (PFBA) is a short chain perfluoroalkyl carboxylate that is structurally similar to perfluorooctanoate. Administration of PFBA can cause peroxisome proliferation, induction of peroxisomal fatty acid oxidation and hepatomegaly, suggesting that PFBA activates the nuclear receptor, peroxisome proliferator-activated receptor-α (PPAR-α). In this study, the role of PPAR-α in mediating the effects of PFBA was examined using PPAR-α null mice and a mouse line expressing the human PPAR-α in the absence of mouse PPAR-α (PPAR-α humanized mice). PFBA caused upregulation of known PPAR-α target genes that modulate lipid metabolism in wild-type and PPAR-α humanized mice, and this effect was not found in PPAR-α null mice. Increased liver weight and hepatocyte hypertrophy were also found in wild-type and humanized PPAR-α mice treated with PFBA, but not in PPAR-α null mice. Interestingly, hepatocyte focal necrosis with inflammatory cell infiltrate was only found in wild-type mice administered PFBA; this effect was markedly diminished in both PPAR-α null and PPAR-α humanized mice. Results from these studies demonstrate that PFBA can modulate gene expression and cause mild hepatomegaly and hepatocyte hypertrophy through a mechanism that requires PPAR-α and that these effects do not exhibit a species difference. In contrast, the PPAR-α-dependent increase in PFBA-induced hepatocyte focal necrosis with inflammatory cell infiltrate was mediated by the mouse PPAR-α but not the human PPAR-α. Collectively, these findings demonstrate that PFBA can activate both the mouse and human PPAR-α, but there is a species difference in the hepatotoxic response to this chemical.

UR - http://www.scopus.com/inward/record.url?scp=67649236155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649236155&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfp077

DO - 10.1093/toxsci/kfp077

M3 - Article

VL - 110

SP - 204

EP - 211

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -

Foreman JE, Chang SC, Ehresman DJ, Butenhoff JL, Anderson CR, Palkar PS et al. Differential hepatic effects of perfluorobutyrate mediated by mouse and human PPAR-α. Toxicological Sciences. 2009 Jun 29;110(1):204-211. https://doi.org/10.1093/toxsci/kfp077